🔗 Share this article

Chancellor Reeves has announced she is planning "targeted action to address cost of living pressures" in next month's financial statement.

During an interview with media outlets, she emphasized that curbing price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven developed nations this calendar year and next.

Possible Energy Bill Interventions

Sources suggest the administration could take action to lower energy bills, for instance by reducing the current 5% rate of VAT charged on energy.

An additional option is to cut some of the government charges presently included in household expenses.

Fiscal Constraints and Expert Expectations

The government will obtain the latest draft from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much room there is for such measures.

The expectation from most analysts is that Reeves will have to announce higher taxes or spending cuts in order to fulfill her declared fiscal targets.

Previously on Thursday, estimates suggested there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the lower end of forecasts.

"There's a collective task between the central bank and the government to further reduce some of the sources of price increases," the Chancellor told reporters in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While much of the attention has been on expected tax increases, the chancellor said the latest figures from the OBR had not altered her commitment to campaign commitments not to increase tax levels on earnings tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with rising international and trade issues for the fiscal tax moves, probably to be directed on those "most able to pay."

International Trade Disputes

Addressing concerns about the United Kingdom's commercial links with China she said: "Our security interests always are paramount."

Last week's declaration by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are key for high-technology production led American leader Donald Trump to threaten an further 100% tariff on goods from China, raising the prospect of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary called the Chinese move "economic coercion" and "a international production control attempt."

Inquired about accepting the American proposal to join its dispute with the Asian nation, Reeves said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "damaging for the global economy and causes further challenges."

"It is my opinion there are areas where we need to challenge Chinese policies, but there are also significant prospects to trade with Chinese markets, including banking sector and other areas of the economy. We've got to get that balance appropriate."

The Treasury chief also affirmed she was working with G7 counterparts "on our own essential resources plan, so that we are more independent."

Health Service Medicine Pricing and Investment

The Chancellor also admitted that the price the National Health Service spends on pharmaceuticals could rise as a consequence of current discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either pausing or abandoning investments in the United Kingdom, with several attributing the low prices they are obtaining.

Last month, the Science Minister said the cost the NHS pays for medicines would must rise to prevent companies and pharmaceutical investment leaving the UK.

Reeves informed media: "We have seen because of the pricing regime, that drug testing, new drugs have not been provided in the United Kingdom in the extent that they are in other continental states."

"Our aim is to ensure that patients getting care from the National Health Service are can access the top critical medicines in the globe. And so we are examining all of that, and... looking to obtain additional funding into Britain."